The latest news from The VIVA Foundation
Don’t miss a thing! Sign up to get the latest announcements, important dates, and news.
News & Updates
A new ground-breaking clinical trial exploring treatments for pelvic venous disorders has launched
March 25, 2024SIR Foundation, The VIVA Foundation, and Penumbra, Inc., announce the start of the EMBOLIZE Trial SALT LAKE CITY (March 25, 2024)—The Society of Interventional Radiology (SIR) Foundation, The VIVA Foundation and Penumbra, Inc., today announced the launch of the EMBOLIZE trial, a first-of-its-kind prospective, randomiz ...
News & Updates
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA23
November 1, 2023The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the last of four Late-Breaking Clinical Trial sessions at the VIVA23 conference, hosted at Wynn Las Vegas. VIVA (Vascular InterVentional Adv ...
News & Updates
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA23
November 1, 2023The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four Late-Breaking Clinical Trial sessions at the VIVA23 conference, hosted at Wynn Las Vegas. VIVA (Vascular InterVentional Ad ...
News & Updates
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA23
October 31, 2023The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four Late-Breaking Clinical Trial sessions at the VIVA23 conference, hosted at Wynn Las Vegas. VIVA (Vascular InterVentional A ...
News & Updates
First Round of Late-Breaking Clinical Trial Results Announced at VIVA23
October 31, 2023The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four Late-Breaking Clinical Trial sessions at the VIVA23 conference, hosted at Wynn Las Vegas. VIVA (Vascular InterVentional Ad ...